Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,124 total articles
Rightmove has been repriced lower on headlines about AI reducing listing value. That narrative is overstated in the near term. The business still generates recurring, high-margin revenue from a dominant UK portal and benefits from structural listing dynamics that are hard to replicate. We present a tactical long with a mid-term horizon that balance…
HIVE Digital is positioning its green-energy data centers to host GPU-based AI compute for customers and partners. The stock is trading at $4.51 with a $1.13B market cap, bullish technicals, rising volume and short interest—an environment ripe for a momentum-driven swing trade. This idea lays out a clear entry, stop and target with a 45-trading-day…
Reddit is showing accelerating monetization and strong profitability metrics while trading well below its 52-week peak. We like a controlled long starting at current price to capture AI licensing tailwinds and continued ad recovery, but valuation is rich and requires strict risk management.
Suzano (SUZ) trades at bargain-basement multiples with a market cap near $10.4B, a forward-like P/E under 5 and a 1.12x PB. Technicals show the stock oversold and short interest has picked up — a setup for a mid-term swing trade. I recommend a long trade with an entry at $8.25, a stop at $7.75 and a target of $10.00 over the next 45 trading days.
Nebius (NBIS) is trading near $229 after a blistering run that reflects real growth: Q1 revenue of $399M (up 684% YoY), an AI cloud business up 841%, and plans to scale capacity toward 800-1,000 MW by year-end. The market cap is $56.9B and the stock carries premium multiples, but the company is profitable, expanding capacity rapidly, and signing la…
DSV's recently announced strategic agreement to integrate a large portion of DB Schenker's operations creates a multi-quarter earnings and margin upside that the market hasn't fully priced in. This trade idea lays out a concrete entry, stop and target with catalysts and risks, and explains why disciplined exposure now offers 30%+ upside over the ne…
Palantir appears to be moving past one-off services and into recurring, high-margin software economics driven by large enterprise AI deployments and Apollo-enabled uptime. This trade aims to capture that re-rating over a multi-month horizon while protecting capital via a defined stop.
Trane Technologies (TT) is often lumped in with traditional HVAC names, but recent product commercialization in high-density liquid cooling and favorable market dynamics position it as a practical infrastructure play for AI-scale data centers. With a market cap near $100 billion, healthy free cash flow, and improving product momentum, this trade ta…
China Yuchai (CYD) has moved rapidly off its 52-week low and is trading near its 52-week high on rising volume, bullish technicals, and positive strategic news. With a compact float and improving investor sentiment, this trade idea targets a mid-term swing (45 trading days) long while managing risk with a clear stop under $50.
SentinelOne plunged after a mixed Q1 and guidance that disappointed markets. With revenue guidance trimmed, pricey valuation metrics and thin free cash flow, the stock looks set for further downside. This trade idea lays out an actionable short entry at $18.00, a stop at $19.50 and a $13.00 target over a short-term 10 trading day horizon, with cont…
Kraft Heinz (KHC) trades at bargain multiples - P/B ~0.69, EV/EBITDA ~8.5 and an FCF yield north of 13% - but earnings remain negative and margins are stretched by commodity shocks. For traders willing to back a recovery, a mid-term long with defined risk offers asymmetric upside into the company's 52-week range and upcoming catalysts like the June…
Constellation Brands (STZ) is trading at a multi-year discount after a guidance reset and sector weakness. The company still generates strong free cash flow, has a reasonable balance sheet and pays a near-3% dividend. Technicals are showing oversold conditions and the stock sits comfortably below its 50-day average. This trade idea lays out an entr…
Vertiv (VRT) looks expensive on headline multiples, but its scale in power and cooling for AI data centers, a $2.3B free cash flow run-rate, and a $15B+ backlog make a disciplined long trade sensible. I outline a mid-term (45 trading days) swing plan with an entry at $318, stop at $290 and target at $380 — risk-weighted, catalyst-driven, and sized …
Ferrari pulled a headline move with its Luce EV reveal; social backlash and investor criticism knocked the stock lower, but fundamentals - scarce supply, industry-leading margins, strong pricing power and a $85.9B market cap - argue for buying dips. This trade lays out an actionable long-term entry with a tight stop and a clear target based on mean…
Taseko Mines (TGB) has moved from developer to producer as Florence Copper records its first cathode harvest and early ramp indicators. With a $2.64B market cap, stretched valuation metrics and a partially priced-in story, the stock offers a tradeable asymmetric opportunity while the market digests production proof. We recommend a tactical long for…
Nvidia (NVDA) remains the central beneficiary of surging AI infrastructure demand. Strong quarterly results, robust free cash flow, expanding addressable market via CPUs and ecosystem partnerships are generating durable pricing and volume tailwinds. Technicals show neutral momentum but volume and short interest dynamics leave room for a sustained m…
Antero Resources looks like a compelling long after recent weakness: solid balance sheet, sub-7x EV/EBITDA, and a path to much higher free cash flow in 2026 in a stronger gas price environment. Our projection models show the company capable of generating north of $1.7 billion in FCF in 2026 under conservative commodity and midstream assumptions. We…
F&G Annuities & Life is trading at single-digit multiples to book and depressed earnings expectations despite $73B AUM, steady sales and a consistent dividend. The market appears to be pricing in near-term execution risk; we see a mid-term swing opportunity with defined risk and >20% upside if fundamentals stabilize and insurers’ multiples re-rate.
Mastercard (MA) is a high-quality, cash-flowing payments network that benefits when consumers and businesses shift away from cash. With market cap near $436B, free cash flow of $17.8B, and an earnings multiple below many growth names, MA offers a trade to own a practical inflation and currency-debasement hedge. Enter around $494.00, target $560.00 …
Personalis is a small-cap cancer-testing specialist showing early signs of a commercial inflection: clinical test volumes for NeXT Personal rose 59% year-over-year even as revenue lagged. With a market cap near $1.15B, heavy institutional flows, and a stretched technical breakout, we initiate with a Buy, actionable entry, targets and stops tailored…
Ionis (IONS) sits on a constructive technical base and a heavy short-interest backdrop while the oligonucleotide/antisense sector is accelerating. With market cap at roughly $12.8B and clear trading support in the mid-$70s, we outline a swing trade to capture upside toward the 52-week high while limiting downside with a tight stop.
Procter & Gamble is a high-quality consumer staple with durable free cash flow, a long dividend streak and valuation that looks reasonable relative to cash generation. We view PG as a buy for patient, income-oriented investors but recommend a defined entry, stop and target to manage macro and execution risk.
Apogee Therapeutics is a clinical-stage biotech with a lead anti-IL-13 program, zumilokibart (APG777), that has shown strong durability in Phase 2 and a runway extended by recent equity raises. The shares pulled back into the low $70s and look like a tactical long for patient traders willing to ride clinical catalysts into late 2026. This trade ide…
The Western Union Company (WU) trades at roughly $8.10 and yields about 11.5% from an annualized dividend of $0.94. With a market cap near $2.53B, free cash flow of $377.7M and EV/EBITDA of 4.9x, WU looks cheap relative to its cash generation. This trade idea lays out an entry, stop and target with catalysts and clear risk controls for a long-term …
TG Therapeutics is a tactical buy after management signaled a stronger 2026 outlook tied to BRIUMVI expansion and continued commercial execution. The company now sports a roughly $6.0 billion market cap, improving revenue traction, and still-constructive valuation metrics versus growth prospects. This trade lays out entry, stop, and target levels a…
